Last week's decision to end the manufacture of a drug widely used in pregnancy raises awkward problems. Part of any solution should be that regulatory authorities are joined in legal suits.
Article PDF
Rights and permissions
About this article
Cite this article
Who says what drugs to license?. Nature 303, 559 (1983). https://doi.org/10.1038/303559a0
Issue Date:
DOI: https://doi.org/10.1038/303559a0